Yüklüyor......
Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells
INTRODUCTION: Tamoxifen is a drug of choice for endocrine-responsive breast tumor patients. However, tamoxifen resistance has become a major concern for the treatment of breast cancer. Combinational therapies of tamoxifen and different drugs are being frequently studied. In the current study, we tes...
Kaydedildi:
| Yayımlandı: | Anticancer Drugs |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4378591/ https://ncbi.nlm.nih.gov/pubmed/19966541 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e328333d557 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|